A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib

---

İLHAN O., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., DEVECİ B., PEHLİVAN M., KAYNAR L., ...Daha Fazla

46th Annual Meeting of the European Society for Blood and Marrow Transplantation, 29 Ağustos 2020, (Tam Metin Bildiri)

• Yayın Türü: Bildiri / Tam Metin Bildiri
• Ankara Üniversitesi Adresli: Evet